Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes

Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes

Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by day in clinical practice across most high-income countries, affecting nearly 25–30% of adults in the general population and u...

Full description

Bibliographic Details
Main Authors: Alessandro Mantovani, Andrea Dalbeni, Giorgia Beatrice, Davide Cappelli, Fernando Gomez-Peralta
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Clinical Medicine
Subjects:
non-alcoholic fatty liver disease
NAFLD
non-alcoholic steatohepatitis
NASH
type 2 diabetes
cardiovascular disease
Online Access:https://www.mdpi.com/2077-0383/11/4/968

Similar Items

Similar Items